Home Stock

Stock Research: Dis-Chem Pharmacies

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Dis-Chem Pharmacies

JNB:DCP ZAE000227831
16
  • Value
    14
  • Growth
    63
  • Safety
    Safety
    40
  • Combined
    20
  • Sentiment
    34
  • 360° View
    360° View
    16
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Dis-Chem Pharmacies Limited is a South Africa-based company retailing and wholesaling affordable healthcare products and pharmaceuticals. It operates in the retail and wholesale industries. The company operates in South Africa. In the last fiscal year, the company had a market cap of $1,546 million, profits of $472 million, and revenue of $2,100 million. The number of employees is not available.

more

ANALYSIS: With an Obermatt 360° View of 16 (better than 16% compared with alternatives), overall professional sentiment and financial characteristics for the stock Dis-Chem Pharmacies are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Dis-Chem Pharmacies. The consolidated Growth Rank has a good rank of 63, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. It ranks higher than 63% of competitors in the same industry. The other indicators are below average, namely the Value, Safety, and Sentiment Ranks.The Value Rank at 14 means that the share price of Dis-Chem Pharmacies is on the high side compared with its peers regarding revenues, profits, and invested capital. The stock price is higher than for 86% of alternative stocks in the same industry. The consolidated Safety Rank has a riskier rank of 40, which means that the company has a riskier financing structure than 60% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. The consolidated Sentiment Rank also has a low rank of 34, indicating professional investors are more pessimistic about the stock than for 66% of alternative investment opportunities. ...read more

more
Strongest Rank Price vs. Book (P/B)
Weakest Rank Stock Returns
Country South Africa
Industry Drug Retail
Size Medium
Website dischemgroup.com
Index
JSE All Shares
Dis-Chem Pharmacies stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 9-Apr-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
14 15 23 23
Growth
63 97 57 53
Safety
Safety
40 47 56 38
Sentiment
34 70 27 43
360° View
360° View
16 75 28 29
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
44 70 54 17
Opinions Change
27 50 29 50
Pro Holdings
n/a 83 31 65
Market Pulse
27 41 40 52
Sentiment
34 70 27 43
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
14 15 23 23
Growth
63 97 57 53
Safety Safety
40 47 56 38
Combined
20 57 36 21
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
41 49 50 43
Price vs. Earnings (P/E)
13 25 31 33
Price vs. Book (P/B)
10 15 18 13
Dividend Yield
47 32 39 33
Value
14 15 23 23
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
76 86 70 56
Profit Growth
33 74 44 50
Capital Growth
19 96 41 17
Stock Returns
93 69 55 85
Growth
63 97 57 53
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
27 31 36 28
Refinancing
48 52 53 51
Liquidity
50 57 60 47
Safety Safety
40 47 56 38

Similar Stocks

Discover high‑ranked alternatives to Dis-Chem Pharmacies and broaden your portfolio horizons.

MTN

JNB:MTN
Country: South Africa
Industry: Wireless Telecommunication
Size: X-Large
Full Stock Analysis

Astral Foods

JNB:ARL
Country: South Africa
Industry: Packaged Foods & Meats
Size: Medium
Full Stock Analysis

Exxaro

JNB:EXX
Country: South Africa
Industry: Coal & Consumable Fuels
Size: Large
Full Stock Analysis

Caxton and CTP Publishers and Printers

JNB:CAT
Country: South Africa
Industry: Publishing
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

The only positive is high growth. The stock is expensive (low Value Rank), risky to finance, and carries critical professional sentiment. This is a risky proposition. Avoid unless you have exceptional conviction that the growth alone will overcome the price and financial risks.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews